DelawareSB 249153rd General Assembly (2024–2026)SenateWALLET

AN ACT TO AMEND TITLE 16 AND TITLE 29 OF THE DELAWARE CODE RELATING TO SUBSTANCE USE HARM REDUCTION.

Sponsored By: Marie Pinkney (Democratic)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

6 provisions identified: 5 benefits, 1 costs, 0 mixed.

More help for harm reduction participants

Delaware harm reduction programs must offer sterile supplies, drug-testing tools, overdose-reversal medicines, and disease-prevention barriers such as condoms. They must provide supply collection and disposal, infection screening, first aid, and wound care. Programs must offer education, training, health care and vaccination referrals, and help with transportation, housing, and eligible public benefits. Programs must provide enough sterile supplies to prevent sharing or reuse, without requiring used supplies in exchange. They must also encourage participants to distribute new, sterile supplies to peers.

Legal protection for harm reduction workers

People carrying out activities under the harm reduction law gain legal protections when acting in good faith with reasonable care. Protection covers criminal liability, professional discipline or other adverse action, and civil liability for injury or death. It does not cover injury or death caused by unreasonable care, willful or wanton conduct, or gross negligence.

Privacy rights for harm reduction participants

Participants can remain anonymous, and programs cannot require information that could reveal their identity. Records are confidential, not public, and protected from discovery in legal proceedings; participants can authorize disclosure in writing. The state generally cannot require data collection or reports, except for specified operational, transaction-level, and program-level information. Programs need state approval for participant research or behavior tracking. Programs cannot require participants to join state-required data collection to receive services.

Fewer drug supplies count as paraphernalia

The law revises which objects count as drug paraphernalia, including production, mixing, packaging, and storage items intended for sale. It excludes legally authorized items, lawful marijuana or tobacco items, drug-testing tools, and items for concealing, containing, or storing drugs. Items used to take drugs, including needles, syringes, and pipes, are also excluded. Authorities must consider 13 factors, including residue, location, statements, sales practices, legitimate uses, and expert testimony. Covered paraphernalia can still be admitted as evidence in investigations or prosecutions.

New framework for harm reduction programs

The law replaces Delaware's prior harm reduction framework in Title 29 with a new chapter in Title 16. It repeals the former Title 29 sections 7990 through 7996. The Division of Substance Abuse and Mental Health can adopt evidence-based rules for program licensing and operation. Programs can use mobile units and peer-delivered services, subject to those rules.

Penalties for covered drug paraphernalia offenses

For objects that remain covered, knowingly possessing or using paraphernalia in violation of the law is a class B misdemeanor. Knowingly delivering, possessing with intent to deliver, converting, making, conveying, selling, or offering it for sale illegally is a class G felony. Those distribution-related offenses involving a child are class E felonies. Knowingly advertising an illegal sale of covered paraphernalia is an unclassified misdemeanor, with a fine up to $1,000 per offense. These classifications replace the repealed penalty section; excluded objects are not subject to these paraphernalia offenses.

Sponsors & Cosponsors

Sponsor

  • Marie Pinkney

    Democratic • Senate

Cosponsors

  • Alonna Berry

    Democratic • House

  • Stephanie T. Bolden

    Democratic • House

  • Nnamdi O. Chukwuocha

    Democratic • House

  • Kendra Johnson

    Democratic • House

  • Kamela T Smith

    Democratic • House

  • Larry Lambert

    Democratic • House

  • Eric Morrison

    Democratic • House

  • DeShanna U Neal

    Democratic • House

  • Cyndie Romer

    Democratic • House

  • Ray Seigfried

    Democratic • Senate

  • David P. Sokola

    Democratic • Senate

  • Laura V. Sturgeon

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 37 • No: 22

House vote • 6/23/2026

Passed (SM required)

Yes: 22 • No: 16

Senate vote • 5/14/2026

Passed (SM required)

Yes: 15 • No: 6

Actions Timeline

  1. Signed by Governor

    9/30/2026Governor
  2. Passed By House. Votes: 22 YES 16 NO 2 NOT VOTING 1 ABSENT

    6/23/2026House
  3. Reported Out of Committee (Health & Human Development) in House with 4 Favorable, 5 On Its Merits

    6/17/2026House
  4. Assigned to Health & Human Development Committee in House

    5/19/2026House
  5. Passed By Senate. Votes: 15 YES 6 NO

    5/14/2026Senate
  6. Amendment SA 2 to SB 249 - Passed By Senate. Votes: 15 YES 1 NO 5 NOT VOTING

    5/14/2026Senate
  7. Amendment SA 2 to SB 249 - Introduced and Placed With Bill

    5/14/2026Senate
  8. Amendment SA 1 to SB 249 - Stricken in Senate

    5/14/2026Senate
  9. Amendment SA 1 to SB 249 - Introduced and Placed With Bill

    5/14/2026Senate
  10. Reported Out of Committee (Health & Social Services) in Senate with 1 Favorable, 4 On Its Merits

    4/22/2026Senate
  11. Introduced and Assigned to Health & Social Services Committee in Senate

    3/5/2026Senate

Bill Text

Related Bills

Back to State Legislation